Vijaypd Ceutical Ltd IPO

Strengthen our market position by increasing the long-term relationship with the clients.

Comprehensive product portfolio.

Streamlined supply chain management.

Experienced management team with proven execution capabilities.

Our company is positioning itself to expand its market presence by diversifying into the manufacturing of ActivePharmaceutical Ingredients (APIs), which serve as raw materials for the formulation of various types of FinishedDosage Forms (FDF) and Excipients. However, this expansion may expose us to several risks that could adverselyaffect our growth, prospects, cash flows, business operations, and financial condition.

We may incur losses, and our reputation may be adversely affected if customers return our products due to thedistribution of expired, unsafe, defective, ineffective, or counterfeit products, as well as product spoilage, breakage, ordamage during transportation or storage. Failure to comply with customer-prescribed quality standards may also resultin loss of business. In addition, we may be subject to product liability claims.

We derive a significant portion of our revenue from customers located in Maharashtra. Any adverse developments inthe region could adversely affect our business, results of operations, cash flows and financial condition.

Our Company is reliant on the demand from the pharmaceutical industry for a significant portion of our revenue. Anydownturn in the pharmaceutical industry or an inability to increase or effectively manage our sales could have anadverse impact on our Companys business and results of operations.

Since our inception, we have completed one of the acquisitions of distributors in India to expand our business andincrease our customer base and may continue to complete more acquisitions in the future. However, we may be unableto realize the anticipated benefits of past or future acquisitions successfully. Further, if we are unable to identifyexpansion opportunities or experience delays or other problems in implementing our strategy of inorganic growth, ourbusiness, financial condition, results of operations, cash flows and prospects may be adversely affected.

We procure a significant portion of our raw materials from suppliers based in the State of Maharashtra. Any adversedevelopments in the region could adversely affect our business, results of operations, cash flows and financial condition.

We do not have long term agreements with our customers, which could adversely impact our business as our customerscan terminate their relationships with us without notice.

We do not have long-term agreements with manufacturer of pharmaceutical products and an increase in the cost of, ora shortfall in the availability or quality of such pharmaceutical products could have an adverse effect on our business,financial condition and results of operations

We have experienced negative cash flows from operating activities in the past and may continue to experience negativecash flows in the future, which could adversely affect our business operations and financial condition.

We have not yet placed orders in relation to the funding Capital Expenditure towards purchase of plant and machinerywhich is proposed to be financed from the Issue proceeds of the IPO. In the event of any delay in placing the orders, orin the event the vendors are not able to provide the Plant and Machinery in a timely manner, or at all, may result in timeand cost over-runs and our business, prospects and results of operations may be adversely affected. Our proposedManufacturing Facility are subject to the risk of unanticipated delays in implementation due to factors including delaysin construction, obtaining regulatory approvals in timely manner and cost overruns.